Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-04-01 Sale |
2021-04-05 5:00 pm |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $51.4 | $356,956 | 50,927 (Direct) |
View |
2021-03-23 Sale |
2021-03-25 5:26 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $53.6 | $423,408 | 411,755 (Direct) |
View |
2021-03-10 Sale |
2021-03-12 4:28 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $48 | $112,320 | 419,655 (Direct) |
View |
2021-03-09 Sale |
2021-03-10 4:58 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
5,560 | $44.8 | $249,086 | 421,995 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 4:35 pm |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $63.44 | $440,531 | 57,871 (Direct) |
View |
2021-02-23 Sale |
2021-02-25 4:25 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $63.74 | $503,577 | 427,555 (Direct) |
View |
2021-02-09 Sale |
2021-02-10 4:33 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $71.16 | $562,161 | 405,455 (Direct) |
View |
2021-02-01 Sale |
2021-02-02 6:00 pm |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $69.91 | $485,424 | 277,777 (Direct) |
View |
2021-01-26 Sale |
2021-01-27 6:39 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
31,300 | $48.17 | $1,507,806 | 413,355 (Direct) |
View |
2021-01-15 Sale |
2021-01-19 5:00 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
10,530 | $38 | $400,140 | 444,655 (Direct) |
View |
2021-01-12 Sale |
2021-01-13 6:38 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $29.36 | $111,696 | 455,185 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 4:40 pm |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,945 | $26.32 | $182,795 | 238,425 (Direct) |
View |
2020-12-22 Sale |
2020-12-23 6:06 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $31.19 | $118,683 | 458,990 (Direct) |
View |
2020-12-08 Sale |
2020-12-10 5:00 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $31.27 | $118,966 | 462,795 (Direct) |
View |
2020-12-01 Sale |
2020-12-02 5:48 pm |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,945 | $31.53 | $218,968 | 291,666 (Direct) |
View |
2020-11-27 Sale |
2020-12-01 7:02 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,930 | $30 | $87,900 | 466,600 (Direct) |
View |
2020-11-24 Sale |
2020-11-25 5:00 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $27.29 | $63,848 | 469,530 (Direct) |
View |
2020-11-10 Sale |
2020-11-12 5:00 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $26.26 | $61,448 | 471,870 (Direct) |
View |
2020-10-21 Sale |
2020-11-05 5:00 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $31.44 | $157,209 | 117,368 (Direct) |
View |
2020-11-02 Sale |
2020-11-03 5:00 pm |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $31.27 | $217,153 | 298,611 (Direct) |
View |
2020-10-27 Sale |
2020-10-28 7:43 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $35.04 | $133,335 | 474,210 (Direct) |
View |
2020-10-21 Sale |
2020-10-22 6:15 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
12,500 | $35.49 | $443,608 | 238,109 (Direct) |
View |
2020-10-13 Sale |
2020-10-14 6:33 pm |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
5,560 | $43.03 | $239,236 | 478,015 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-04-01 Exercise |
2021-04-05 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
4,629 | $1.485 | 50,927 (Direct) |
View |
2021-04-01 Exercise |
2021-04-05 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
2,315 | $1.575 | 50,927 (Direct) |
View |
2021-04-01 Exercise |
2021-04-05 5:00 pm |
N/A 2027-10-05 |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $0 | 50,927 (Direct) |
View |
2021-03-30 Other |
2021-04-01 5:25 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
1,011,976 | $0 | 16,640,068 (Indirect) |
View |
2021-03-30 Other |
2021-04-01 5:24 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,008,350 | $0 | 16,626,496 (Indirect) |
View |
2021-03-29 Option Award |
2021-03-31 6:17 pm |
N/A 2031-03-28 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:26 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $1.53 | 411,755 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:26 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $0 | 411,755 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 4:28 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $1.53 | 419,655 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 4:28 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $0 | 419,655 (Direct) |
View |
2021-03-09 Exercise |
2021-03-10 4:58 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
5,560 | $1.53 | 421,995 (Direct) |
View |
2021-03-09 Exercise |
2021-03-10 4:58 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
5,560 | $0 | 421,995 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 4:35 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
4,630 | $1.485 | 57,871 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 4:35 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
2,314 | $1.575 | 57,871 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 4:35 pm |
N/A 2027-10-05 |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $0 | 57,871 (Direct) |
View |
2021-02-23 Exercise |
2021-02-25 4:25 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
18,900 | $1.53 | 427,555 (Direct) |
View |
2021-02-23 Exercise |
2021-02-25 4:25 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
18,900 | $0 | 427,555 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:01 pm |
N/A 2031-02-15 |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
75,000 | $0 | 252,777 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:01 pm |
N/A 2031-02-15 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
90,000 | $0 | 123,200 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 5:01 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
10,000 | $0.855 | 207,110 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 5:01 pm |
N/A 2027-03-09 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
10,000 | $0 | 207,110 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:01 pm |
N/A 2031-02-15 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
96,000 | $0 | 207,110 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:01 pm |
N/A 2031-02-15 |
Vir Biotechnology Inc. | VIR | Rice Steven J. Chief Administrative Officer |
60,000 | $0 | 60,000 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:01 pm |
N/A 2031-02-15 |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
333,000 | $0 | 6,853,888 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 5:25 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
10,000 | $0.855 | 111,110 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 5:25 pm |
N/A 2027-03-09 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
10,000 | $0 | 111,110 (Direct) |
View |
Ownership |
2021-02-12 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
0 | $0 | 6,520,888 (Indirect) |
View |
2020-12-02 Ownership |
2021-02-12 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
215,000 | $0 | 6,520,888 (Direct) |
View |
2020-04-03 Ownership |
2021-02-12 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
106,481 | $0 | 9,260 (Direct) |
View |
2021-02-09 Exercise |
2021-02-10 4:33 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $1.53 | 405,455 (Direct) |
View |
2021-02-09 Exercise |
2021-02-10 4:33 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,900 | $0 | 405,455 (Direct) |
View |
2021-02-01 Exercise |
2021-02-02 6:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
2,314 | $1.485 | 277,777 (Direct) |
View |
2021-02-01 Exercise |
2021-02-02 6:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
4,630 | $1.575 | 277,777 (Direct) |
View |
2021-02-01 Exercise |
2021-02-02 6:00 pm |
N/A 2027-10-05 |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $0 | 277,777 (Direct) |
View |
2021-01-26 Exercise |
2021-01-27 6:39 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
31,300 | $1.53 | 413,355 (Direct) |
View |
2021-01-26 Exercise |
2021-01-27 6:39 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
31,300 | $0 | 413,355 (Direct) |
View |
2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
10,530 | $1.53 | 444,655 (Direct) |
View |
2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
10,530 | $0 | 444,655 (Direct) |
View |
2021-01-12 Exercise |
2021-01-13 6:38 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $1.53 | 455,185 (Direct) |
View |
2021-01-12 Exercise |
2021-01-13 6:38 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $0 | 455,185 (Direct) |
View |
2021-01-04 Exercise |
2021-01-05 4:40 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,945 | $1.485 | 238,425 (Direct) |
View |
2020-12-01 Exercise |
2021-01-05 4:40 pm |
N/A 2027-10-05 |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,945 | $0 | 238,425 (Direct) |
View |
2020-12-24 Exercise |
2020-12-28 6:39 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
9,500 | $1.53 | 458,990 (Direct) |
View |
2020-12-24 Exercise |
2020-12-28 6:39 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
9,500 | $0 | 458,990 (Direct) |
View |
2020-12-22 Exercise |
2020-12-23 6:06 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $1.53 | 458,990 (Direct) |
View |
2020-12-22 Exercise |
2020-12-23 6:06 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $0 | 458,990 (Direct) |
View |
2020-12-09 Option Award |
2020-12-11 4:42 pm |
N/A 2030-12-08 |
Vir Biotechnology Inc. | VIR | Hatfield Jeffrey S. Director |
46,500 | $0 | 46,500 (Direct) |
View |
2020-12-08 Exercise |
2020-12-10 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $1.53 | 462,795 (Direct) |
View |
2020-12-08 Exercise |
2020-12-10 5:00 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $0 | 462,795 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 5:48 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
4,630 | $1.485 | 291,666 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 5:48 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
2,315 | $1.575 | 291,666 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 5:48 pm |
N/A 2027-10-05 |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,945 | $0 | 291,666 (Direct) |
View |
2020-11-27 Exercise |
2020-12-01 7:03 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
7,500 | $0.855 | 111,110 (Direct) |
View |
2020-11-27 Exercise |
2020-12-01 7:03 pm |
N/A 2027-03-09 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
7,500 | $0 | 111,110 (Direct) |
View |
2020-11-27 Exercise |
2020-12-01 7:02 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,930 | $1.53 | 466,600 (Direct) |
View |
2020-11-27 Exercise |
2020-12-01 7:02 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,930 | $0 | 466,600 (Direct) |
View |
2020-11-24 Exercise |
2020-11-25 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $1.53 | 469,530 (Direct) |
View |
2020-11-24 Exercise |
2020-11-25 5:00 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $0 | 469,530 (Direct) |
View |
2020-11-12 Exercise |
2020-11-16 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
20,000 | $0.855 | 111,110 (Direct) |
View |
2020-11-12 Exercise |
2020-11-16 5:00 pm |
N/A 2027-03-09 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
20,000 | $0 | 111,110 (Direct) |
View |
2020-11-10 Exercise |
2020-11-12 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $1.53 | 471,870 (Direct) |
View |
2020-11-10 Exercise |
2020-11-12 5:00 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
2,340 | $0 | 471,870 (Direct) |
View |
2020-11-04 Exercise |
2020-11-05 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.53 | 117,368 (Direct) |
View |
2020-10-21 Exercise |
2020-11-05 5:00 pm |
N/A 2028-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 117,368 (Direct) |
View |
2020-11-02 Exercise |
2020-11-03 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
4,629 | $1.485 | 298,611 (Direct) |
View |
2020-11-02 Exercise |
2020-11-03 5:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
2,315 | $1.575 | 298,611 (Direct) |
View |
2020-11-02 Exercise |
2020-11-03 5:00 pm |
N/A 2027-10-05 |
Vir Biotechnology Inc. | VIR | Parrish Jay Chief Business Officer |
6,944 | $0 | 298,611 (Direct) |
View |
2020-10-27 Exercise |
2020-10-28 7:43 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $1.53 | 474,210 (Direct) |
View |
2020-10-27 Exercise |
2020-10-28 7:43 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
3,805 | $0 | 474,210 (Direct) |
View |
2020-10-21 Exercise |
2020-10-22 6:15 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
2,315 | $5.175 | 238,109 (Direct) |
View |
2020-10-21 Exercise |
2020-10-22 6:15 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
7,870 | $1.53 | 238,109 (Direct) |
View |
2020-10-21 Exercise |
2020-10-22 6:15 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
2,315 | $1.575 | 238,109 (Direct) |
View |
2020-10-21 Exercise |
2020-10-22 6:15 pm |
N/A 2028-04-27 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
12,500 | $0 | 238,109 (Direct) |
View |
2020-10-13 Exercise |
2020-10-14 6:33 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
5,560 | $1.53 | 478,015 (Direct) |
View |
2020-10-13 Exercise |
2020-10-14 6:33 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
5,560 | $0 | 478,015 (Direct) |
View |